Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 7th, 2021 |
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) |
National Institutes of Health |
July 16th, 2018 |
Geriatrics and Clinical Gerontology Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Not Allowed) |
National Institutes of Health |
June 10th, 2018 |
Assisting the Ministry of Health and Social Services (MOHSS) in Providing Critical Human Resources for Health to Achieve HIV Epidemic Control in Namibia under PEPFAR |
Centers for Disease Control CGH |
June 30th, 2018 |
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2021 |
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
May 7th, 2021 |
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) |
National Institutes of Health |
July 27th, 2018 |
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 1st, 2018 |
Domestic Violence Prevention Initiative |
Indian Health Service |
June 11th, 2018 |
Community Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk for Psychosis (Short Title: CHR-P) |
Substance Abuse and Mental Health Services Adminis |
September 7th, 2021 |
Making Health care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18) |
Agency for Health Care Research and Quality |
January 25th, 2021 |
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
July 1st, 2018 |
Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) |
National Institutes of Health |
November 13th, 2020 |
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional) |
National Institutes of Health |
November 13th, 2020 |
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional) |
National Institutes of Health |
June 29th, 2018 |
FY18 Announcement of the Availability of Funds for Phase I New and Innovative Strategies (Tier 2) to Prevent Teenage Pregnancy and Promote Healthy Adolescence |
Office of the Assistant Secretary for Health |
June 11th, 2018 |
Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke-Financed in part by 2018 Prevention and Public Health Funds (PPHF) |
Centers for Disease Control NCCDPHP |
June 29th, 2018 |
FY18 Announcement of Availability of Funds for Phase I Replicating Programs (Tier 1) Effective in the Promotion of Healthy Adolescence and the Reduction of Teenage Pregnancy and Associated Risk Behaviors |
Office of the Assistant Secretary for Health |
August 28th, 2020 |
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
National Institutes of Health |
July 2nd, 2018 |
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 4th, 2018 |
Distance Learning and Telemedicine Grant Program |
Utilities Programs |
|
April 2nd, 2019 |
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 2nd, 2019 |
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2021 |
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) |
National Institutes of Health |
June 11th, 2018 |
Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
December 6th, 2018 |
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 30th, 2018 |
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) |
National Institutes of Health |
October 30th, 2018 |
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) |
National Institutes of Health |
February 11th, 2021 |
Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
October 30th, 2018 |
Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) |
National Institutes of Health |
October 30th, 2018 |
Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 9th, 2018 |
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
August 31st, 2018 |
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2021 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). |
National Institutes of Health |
May 7th, 2021 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). |
National Institutes of Health |
June 3rd, 2018 |
National Center of Excellence for Tobacco-Free Recovery (Short Title: National Center - TFR) |
Substance Abuse and Mental Health Services Adminis |
May 24th, 2019 |
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) |
National Institutes of Health |
January 22nd, 2021 |
Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional) |
National Institutes of Health |
January 22nd, 2021 |
Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) |
National Institutes of Health |